This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Enhancing Pharmacologic Effects in the Treatment of Depression in Women

Susan G. Kornstein, MD, and Geoffry McEnany, RN, PhD, CS

Published: September 30, 2000

Article Abstract

The prevalence of depressive disorders in women is twice that in men. This gender differenceemerges around the time of puberty and persists through the childbearing years. Reproductive eventsand psychosocial factors are important influences on depression in women. Women often present withatypical depressive symptoms and comorbid disorders that can complicate both diagnosis and treatment.Sex differences in pharmacokinetics have been noted, as well as differences in antidepressanttreatment response. While sleep disturbances, sexual dysfunction, and weight gain may be part of theconstellation of depressive symptoms, they are also important considerations in selecting a treatmentoption for depressed women.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 61

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Young-Adult Social Outcomes of Attention-Deficit/Hyperactivity Disorder

ADHD that persisted into young-adulthood was associated with poorer outcomes in terms of education, employment, and emotional...

Read More...